# Phase 4 – Optimisation & Scaling
**Timeline:** 01 Jul – 30 Dec 2026  
**Timezone:** Africa/Johannesburg

## Phase Outcome
Programmes refined for margin and quality; partnerships secured; performance ≥ break-even with surplus.

---

## Milestones

### P4-M1: Pricing Adjustment
- **Owner:** Finance
- **Due:** 01 Jul 2026
- **Status:** ⏳ PLANNED

**Description:**  
Cost-to-serve analysis; revise tariffs; publish update.

**Expected Outcome:**  
Sustainable fee structure with ≥5% operating margin.

**Checklist:**
- [ ] Conduct cost-to-serve analysis (all service lines)
- [ ] Calculate direct costs per client/session
- [ ] Allocate overhead fairly
- [ ] Benchmark against market rates
- [ ] Identify loss-making streams
- [ ] Model pricing scenarios (3–5 options)
- [ ] Target ≥5% margin per stream
- [ ] Consult with clinical leads on feasibility
- [ ] Draft revised pricing schedule
- [ ] Present to board for approval
- [ ] Publish updated pricing internally & externally
- [ ] Notify medical aids of tariff changes

---

### P4-M2: Medical-Aid Panel Expansion
- **Owner:** Admin
- **Due:** 15 Jul 2026
- **Status:** ⏳ PLANNED

**Description:**  
Apply to additional schemes; update accreditation files.

**Expected Outcome:**  
Broader payer base; shorter claim turnaround.

**Checklist:**
- [ ] Identify target medical-aid schemes (not yet on panel)
- [ ] Review application requirements per scheme
- [ ] Update facility accreditation documentation
- [ ] Submit panel applications (≥3 schemes)
- [ ] Follow up on application status weekly
- [ ] Address queries/gaps promptly
- [ ] Obtain panel approval
- [ ] Update billing system with new codes
- [ ] Train billing team on new schemes
- [ ] Monitor claim turnaround times
- [ ] Report DSO improvement

---

### P4-M3: Corporate Partnerships
- **Owner:** CEO/Comms
- **Due:** 01 Sep 2026
- **Status:** ⏳ PLANNED

**Description:**  
Pitch aftercare/prevention offers to employers and EAPs.

**Expected Outcome:**  
≥2 corporate contracts signed.

**Checklist:**
- [ ] Identify target corporates (≥500 employees)
- [ ] Map EAP providers in region
- [ ] Design corporate wellness package
- [ ] Create employer pitch deck
- [ ] Schedule meetings with HR/wellness managers
- [ ] Deliver presentations (≥10 meetings)
- [ ] Tailor proposals to specific needs
- [ ] Negotiate pricing and SLAs
- [ ] Draft contracts
- [ ] Sign ≥2 corporate contracts
- [ ] Set up corporate billing process
- [ ] Launch first corporate programme

---

### P4-M4: Quality Audit
- **Owner:** Clinical Lead
- **Due:** 01 Oct 2026
- **Status:** ⏳ PLANNED

**Description:**  
Review outcomes, satisfaction, compliance; CAPA plan.

**Expected Outcome:**  
Continuous-improvement actions implemented.

**Checklist:**
- [ ] Review clinical outcomes (Jan–Sep)
- [ ] Analyze client satisfaction scores
- [ ] Audit compliance with protocols
- [ ] Review incident reports
- [ ] Conduct staff competency review
- [ ] Identify quality gaps
- [ ] Conduct root-cause analysis
- [ ] Draft Corrective & Preventive Action (CAPA) plan
- [ ] Assign CAPA owners and deadlines
- [ ] Implement corrective actions
- [ ] Monitor effectiveness
- [ ] Report to board quality committee

---

### P4-M5: Financial Review #2
- **Owner:** Finance
- **Due:** 15 Nov 2026
- **Status:** ⏳ PLANNED

**Description:**  
Profitability by service line; flag underperformers.

**Expected Outcome:**  
Resource shift toward high-margin streams.

**Checklist:**
- [ ] Calculate profitability by service line (Jul–Oct)
- [ ] Identify high-margin performers
- [ ] Flag underperforming or loss-making streams
- [ ] Analyze root causes of underperformance
- [ ] Model resource reallocation scenarios
- [ ] Propose investment in high-margin streams
- [ ] Propose wind-down or pivot for losers
- [ ] Present to executive team
- [ ] Get approval for resource shifts
- [ ] Communicate changes to operational leads
- [ ] Update 2027 budget assumptions

---

### P4-M6: 2027 Scaling Plan
- **Owner:** Board Committee
- **Due:** 30 Dec 2026
- **Status:** ⏳ PLANNED

**Description:**  
Define staffing, marketing, funding for next cycle.

**Expected Outcome:**  
Approved roadmap for 2027 growth.

**Checklist:**
- [ ] Review 2026 performance (all streams)
- [ ] Define 2027 revenue targets
- [ ] Model staffing requirements
- [ ] Estimate marketing investment
- [ ] Identify infrastructure needs
- [ ] Assess funding options (grants/loans/surplus)
- [ ] Draft 2027 business plan
- [ ] Propose scaling priorities
- [ ] Present to board
- [ ] Get board approval
- [ ] Finalize 2027 budget
- [ ] Communicate plan to all staff

---

## Phase 4 Success Criteria
- ✅ Revised pricing achieves ≥5% margin per stream
- ✅ Panel expanded to ≥3 additional medical aids
- ✅ ≥2 corporate contracts signed and operational
- ✅ Quality audit completed with CAPA plan
- ✅ Resource reallocation toward high-margin streams
- ✅ 2027 scaling plan approved by board
- ✅ Performance at or above break-even

---

## Financial Targets (Phase 4)
**Jul – Dec 2026 (6 months)**

| Service Line | Target Clients | Expected Revenue | Status |
|--------------|----------------|------------------|--------|
| 28-Day Inpatient | 60 admissions | R1,800,000 | ⏳ |
| Adult OP | 30 participants | R225,000 | ⏳ |
| Adolescent OP | 18 participants | R108,000 | ⏳ |
| Aftercare | 40 subscriptions | R200,000 | ⏳ |
| School Outreach | 8 workshops | R48,000 | ⏳ |
| Corporate Contracts | 2 contracts | R120,000 | ⏳ |
| **Phase 4 Total** | - | **R2,501,000** | ⏳ |

**Required monthly run-rate:** R175,000  
**Phase 4 run-rate:** R416,833/month ✅✅

---

## Risk Register (Phase 4)

| Risk | Impact | Likelihood | Mitigation | Owner |
|------|--------|------------|------------|-------|
| Pricing changes drive clients away | High | Medium | Phase increases; communicate value; grandfather existing | Finance |
| Medical-aid applications rejected | Medium | Medium | Pre-consult with schemes; ensure docs complete | Admin |
| Corporate negotiations stall | Medium | High | Pipeline ≥10 prospects; flexible pricing; testimonials | CEO |
| Quality issues discovered in audit | High | Low | Proactive monitoring; staff training; rapid CAPA | Clinical Lead |
| Underperforming streams resist closure | Medium | Medium | Data-driven case; consult staff; phased transition | CEO |
| 2027 funding gap | High | Medium | Apply for grants Q3; explore loan options; surplus retention | Finance |

---

## Next Phase Preview
**Phase 5 – Consolidation & Impact** starts 01 Jan 2027  
Focus: Prove sustainability; document insights; position for 3-year plan.
